Skip to main content

Table 4 Associations between participation in follow-up screening and treatment with glucose lowering agents

From: Associations between follow-up screening after gestational diabetes and early detection of diabetes – a register based study

  Crude OR (95% CI) Adjusted* OR (95% CI)
General practitioner   
Control 1: Within 3 months after birth 2.2 (1.5-3.5) 2.3 (1.5-3.5)
Control 2: 3 months to 2 years 7.4 (5.1-10.6) 7.1 (4.9-10.3)
Control 3: 2 years to 4 years 8.1 (5.9-11.2) 8.1 (5.9-11.3)
Control 4: 4 years to 6 years 8.8 (6.5-12.1) 8.9 (6.5-12.2)
Biochemical unit**   
Control 1: Within 6 months after birth 3.1 (1.7-5.5) 2.9 (1.6-5.3)
Control 2: 6 months to 2.4 years 3.8 (2.0-7.3) 3.5 (1.8-6.9)
Control 3: 2.4 years to 4.5 years 3.3 (1.2-8.9) 2.5 (0.8-7.4)
Control 4: 4.5 years to 8.2 years 7.9 (1.4-43.8) 8.7 (1.5-49.4)
  1. Women with onset of new pregnancy/birth or occurrence of death were excluded from the analysis.
  2. *Adjusted for income, age and ethnicity.
  3. **Data on blood samples are only available for women giving birth after 2006.